The BH3 domain of Bcl-x(S) is required for inhibition of the antiapoptotic function of Bcl-x(L)

Molecular and Cellular Biology

Volumn 19, Issue 10, 1999, Pages 6673-6681

  Chang, Brian S ^a,b   Kelekar, Ameeta ^a,b   Harris, Marian H ^a,b,d   Harlan, John E ^c   Fesik, Stephen W ^c   Thompson, Craig B ^a,b,d  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c ABBOTT LABORATORIES   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROTEIN BCL X;

APOPTOSIS; ARTICLE; CELL SURVIVAL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FAMILY; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 0032874876     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.19.10.6673     Document Type: Article

References (40)

1. Boise, L. H., M. Gonzalez-Garcia, C. E. Postema, L. Ding, T. Lindsten, L. A. Turka, X. Mao, G. Nunez, and C. B. Thompson. 1993. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608.
2. L and Bcl-2. EMBO J. 16:968-977.
3. Chen, G., P. E. Branton, E. Yang, S. J. Korsmeyer, and G. C. Shore. 1996. Adenovirus E1B 19-kDa death suppressor protein interacts with Bax but not with Bad. J. Biol. Chem. 271:24221-24225.
4. Cheng, E. H.-Y., D. G. Kirsch, R. J. Clem, R. Ravi, M. B. Kastan, A. Bedi, K. Ueno, and J. M. Hardwick. 1997. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278:1966-1968.
5. Clarke, M. F., I. J. Apel, M. A. Benedict, P. G. Eipers, V. Sumantran, M. Gonzalez-Garcia, M. Doedens, N. Fukunaga, B. Davidson, J. E. Dick, et al. 1995. A recombinant bcl-xs adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells. Proc. Natl. Acad. Sci. USA 92:11024-11028.
6. L through caspase interaction. Proc. Natl. Acad. Sci. USA 95:554-559.
7. Cosulich, S. C., V. Worall, P. J. Hedge, S. Green, and P. R. Clarke. 1997. Regulation of apoptosis by BH3 domains in a cell-free system. Curr. Biol. 7:913-920.
8. Dixon, E. P., D. T. Stephenson, J. A. Clemens, and S. P. Little. 1997. Bcl-xshort is elevated following severe global ischemia in rat brains. Brain Res. 776:222-229.
9. S enhances adenoviral vector-induced apoptosis in neuroblastoma cells. Cancer Res. 56:5734-5740.
10. Ealovega, M. W., P. K. McGinnis, V. N. Sumantran, M. F. Clarke, and M. S. Wicha. 1996. bcl-xs gene therapy induces apoptosis of human mammary tumors in nude mice. Cancer Res. 56:1965-1969.
11. Fang, W., J. J. Rivard, D. L. Mueller, and T. W. Behrens. 1994. Cloning and molecular characterization of mouse bcl-x in B and T lymphocytes. J. Immunol. 153:4388-4398.
12. Gietz, D., A. St. Jean, R. A. Woods, and R. H. Schiestl. 1992. Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res. 20:1425.
13. Gonzalez-Garcia, M., I. Garcia, L. Ding, S. O'Shea, L. H. Boise, C. B. Thompson, and G. Nunez. 1995. bcl-x is expressed in embryonic and post-natal neural tissues and functions to prevent neuronal cell death. Proc. Natl. Acad. Sci. USA 92:4304-4308.
14. Han, J., P. Sabbatini, and E. White. 1996. Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K. Mol. Cell. Biol. 16:5857-5864.
15. Heermeier, K., M. Benedict, M. Li, P. Furth, G. Nunez, and L. Hennighausen. 1996. Bax and Bcl-xs are induced at the onset of apoptosis in involuting mammary epithelial cells. Mech. Dev. 56:197-207.
16. Huang, D. C., J. M. Adams, and S. Cory. 1998. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4. EMBO J. 17:1029-1039.
17. Hunter, J. J., B. L. Bond, and T. G. Parslow. 1996. Functional dissection of the human Bcl2 protein: sequence requirements for inhibition of apoptosis. Mol. Cell. Biol. 16:877-883.
18. L. EMBO J. 16:1686-1694.
19. L. Mol. Cell. Biol. 17:7040-7046.
20. Kelekar, A., and C. B. Thompson. 1998. Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell. Biol. 8:324-330.
21. Krajewski, S., M. Krajewska, A. Shabaik, H. G. Wang, S. Irie, L. Fong, and J. C. Reed. 1994. Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res. 54:5501-5507.
22. Lamm, G. M., P. Steinlein, M. Cotten, and G. Christofori. 1997. A rapid, quantitative and inexpensive method for detecting apoptosis by flow cytometry in transiently transfected cells. Nucleic Acids Res. 25:4855-4857.
23. Martinou, I., P. A. Fernandez, M. Missotten, E. White, B. Allet, R. Sadoul, and J. C. Martinou. 1995. Viral proteins E1B19K and p35 protect sympathetic neurons from cell death induced by NGF deprivation. J. Cell Biol. 128:201-208.
24. L. J. Biol. Chem. 271:6306-6312.
25. L regulates apoptosis by heterodimerization-dependent and -independent mechanisms. EMBO J. 18:632-643.
26. Mumberg, D., R. Muller, and M. Funk. 1994. Regulatable promoters of Saccharomyces cerevisiae: comparison of transcriptional activity and their use for heterologous expression. Nucleic Acids Res. 22:5767-5768.
27. Nguyen, M., D. G. Millar, V. W. Yong, S. J. Korsmeyer, and G. C. Shore. 1993. Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. J. Biol. Chem. 268:25265-25268.
28. Pena, J. C., E. Fuchs, and C. B. Thompson. 1997. Bcl-x expression influences keratinocyte cell survival but not terminal differentiation. Cell Growth Differ. 8:619-629.
29. Sato, T., M. Hanada, S. Bodrug, S. Irie, N. Iwama, L. H. Boise, C. B. Thompson, E. Golemis, L. Fong, H. G. Wang, et al. 1994. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA 91:9238-9242.
30. L/Bak peptide complex reveals how regulators of apoptosis interact. Science 275:983-986.
31. Schendel, S. L., Z. Xie, M. O. Montal, S. Matsuyama, M. Montal, and J. C. Reed. 1997. Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA 94:5113-5118.
32. Sedlak, T. W., Z. N. Oltvai, E. Yang, K. Wang, L. H. Boise, C. B. Thompson, and S. J. Korsmeyer. 1995. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. USA 92:7834-7838.
33. L. J. Biol. Chem. 271:22764-22772.
34. Sumantran, V. N., M. W. Ealovega, G. Nunez, M. F. Clarke, and M. S. Wicha. 1995. Overexpression of Bcl-xS sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res. 55:2507-2510.
35. Wang, K., X. M. Yin, D. T. Chao, C. L. Milliman, and S. J. Korsmeyer. 1996. BID: a novel BH3 domain-only death agonist. Genes Dev. 10:2859-2869.
36. Wolter, K. G., Y.-T. Hsu, C. L. Smith, A. Nechushtan, X.-G. Xi, and R. J. Youle. 1997. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139:1281-1292.
37. Yang, X. F., G. F. Weber, and H. Cantor. 1997. A novel Bcl-x isoform connected to the T cell receptor regulates apoptosis in T cells. Immunity 7:629-639.
38. Yin, X. M., Z. N. Oltval, and S. J. Korsmeyer. 1994. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369:321-323.
39. Zha, H., H. A. Fisk, M. P. Yaffe, N. Mahajan, B. Herman, and J. C. Reed. 1996. Structure-function comparisons of the proapoptotic protein Bax in yeast and mammalian cells. Mol. Cell. Biol. 16:6494-6508.
40. Zha, H., and J. C. Reed. 1997. Heterodimerization-independent functions of the cell death regulatory proteins Bax and Bcl-2 in yeast and mammalian cells. J. Biol. Chem. 272:31482-31488.